CNBX Pharmaceuticals (CNBX) Notes Payables (2022 - 2025)
CNBX Pharmaceuticals (CNBX) has disclosed Notes Payables for 6 consecutive years, with $40000.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Notes Payables fell 96.99% year-over-year to $40000.0, compared with a TTM value of $40000.0 through Nov 2025, down 96.99%, and an annual FY2024 reading of $1.3 million, down 3.61% over the prior year.
- Notes Payables was $40000.0 for Q4 2025 at CNBX Pharmaceuticals, down from $1.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $1.4 million in Q1 2025 and bottomed at $40000.0 in Q4 2025.
- Average Notes Payables over 4 years is $1.1 million, with a median of $1.3 million recorded in 2023.
- The sharpest move saw Notes Payables soared 487.59% in 2023, then plummeted 96.99% in 2025.
- Year by year, Notes Payables stood at $223645.0 in 2022, then skyrocketed by 487.59% to $1.3 million in 2023, then increased by 1.07% to $1.3 million in 2024, then tumbled by 96.99% to $40000.0 in 2025.
- Business Quant data shows Notes Payables for CNBX at $40000.0 in Q4 2025, $1.3 million in Q2 2025, and $1.4 million in Q1 2025.